Practical Considerations for Developing PICO Statements for Humanistic Burden Reviews: How to Get It Right

Author(s)

Radhakrishnan A1, Sarri G2, Faulkner MR1, Rutherford M2, Zannat NE1, Humphries B3
1Cytel Inc., Waltham, MA, USA, 2Cytel Inc., London, UK, 3Cytel Inc., Kanata, ON, Canada

Presentation Documents

OBJECTIVES: The PICO (Population, Intervention, Comparator, Outcome) statement is the most widely accepted framework for defining the scope of systematic reviews. However, this framework mainly meets the requirements of clinical reviews, which do not fully consider the complexities of humanistic reviews. The objectives are to 1. Review existing guidelines for developing PICO statements for humanistic reviews and their application in practice; 2. Provide practical PICO considerations for humanistic reviews.

METHODS: A targeted search of health technology assessment websites and methodological bodies was performed to identify guidance frameworks. Additionally, we searched MEDLINE for humanistic reviews (all indications) published from 2017-present. Eligible reviews were assessed to determine how the PICO statement was developed and the inclusion rate based on screening criteria. Using this review and the authors’ experiences, guidance on developing PICO statements for burden reviews is presented.

RESULTS: A total of 27 humanistic reviews were included and all used the PICO framework. The proportion of eligible included studies ranged from 0.23%-8.05%, indicating low sensitivity of search strategies. To increase searches’ sensitivity and guide selection criteria, we propose: Identifying a distinct population (e.g., disease severity, subgroups, comorbidities); Explicitly outlining whether to prioritize generic, disease-specific scales, or different versions (e.g., EQ-5D-3L versus EQ-5D-5L); Avoiding vague outcomes (e.g., ‘functional status’); Limiting the type of respondent (e.g., patients, clinicians, caregivers); Creating an a priori list of effect estimates (e.g., mean scores, change from baseline) and time points based on clinical relevance; Implementing sample size, study design, and time restrictions.

CONCLUSIONS: Comprehensively understanding the humanistic disease burden through systematic reviews is fundamental when assessing the value of new health technologies. As the volume of evidence for humanistic reviews has increased drastically over recent years, specific guidance for developing PICO statements is required. Our practical considerations will guide researchers in this area and avoid unnecessary work during evidence selection and synthesis.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

SA45

Topic

Study Approaches

Topic Subcategory

Literature Review & Synthesis

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×